2021 UK Tumor Marker Testing Market--Competitive Shares and Strategic SWOT Analysis, Volume and Sales Segmentation Forecasts for Major Cancer Diagnostic Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 UK Tumor Marker Testing Market--Competitive Shares and Strategic SWOT Analysis, Volume and Sales Segmentation Forecasts for Major Cancer Diagnostic Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

  • April 2021 •
  • Report ID: 6058623 •
  • Format: PDF
2021 UK Tumor Marker Testing Market--Competitive Shares and Strategic SWOT Analysis, Volume and Sales Segmentation Forecasts for Major Cancer Diagnostic Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

This unique report provides information and analysis not available from any other published source.

The report is available by section, and can be customized to specific information needs and budget.

Highlights

  • Comprehensive 575-page analysis of the UK tumor marker testing market.
  • Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
  • Five-year test volume and sales forecasts over for 40 tumor marker performed in UK hospitals, commercial laboratories and physician offices.
  • Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
  • Current instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&;D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

Contains 575 pages and 85 tables



Companies Profiled

Company Assessments

- Abbott
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Clinical Genomics
- Decode Genetics
- DiaSorin
- Diazyme
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic
- Janssen Diagnostics
- Kyowa Medex
- Leica Biosystems
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- PerkinElmer
- Polymedco
- Qiagen
- Quest Diagnostics
- Roche
- Scienion
- Sequenom
- Siemens Healthineers
- Takara Bio
- Theradiag
- Thermo Fisher
- Tosoh
- Vermillion
- Wako Pure Chemicals